1. Home
  2. HUN vs GH Comparison

HUN vs GH Comparison

Compare HUN & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$10.92

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$112.15

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
GH
Founded
1970
2011
Country
United States
United States
Employees
N/A
2021
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
13.2B
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
HUN
GH
Price
$10.92
$112.15
Analyst Decision
Hold
Strong Buy
Analyst Count
11
21
Target Price
$10.23
$99.48
AVG Volume (30 Days)
4.2M
1.8M
Earning Date
02-17-2026
02-19-2026
Dividend Yield
3.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,780,000,000.00
$902,569,000.00
Revenue This Year
N/A
$35.00
Revenue Next Year
$3.31
$26.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.38
52 Week Low
$7.30
$33.75
52 Week High
$18.53
$112.43

Technical Indicators

Market Signals
Indicator
HUN
GH
Relative Strength Index (RSI) 68.27 70.14
Support Level $9.90 $97.31
Resistance Level $10.47 $104.75
Average True Range (ATR) 0.38 3.83
MACD 0.02 0.26
Stochastic Oscillator 82.67 99.25

Price Performance

Historical Comparison
HUN
GH

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: